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Abstract
Background: Most randomized controlled trials of interventions designed to promote cancer screening, particularly
those targeting poor and minority patients, enroll selected patients. Relatively little is known about the benefits of
these interventions among unselected patients.
Methods/Design: “Get Screened” is an American Cancer Society-sponsored randomized controlled trial designed
to promote mammography and colorectal cancer screening in a primary care practice serving low-income patients.
Eligible patients who are past due for mammography or colorectal cancer screening are entered into a tracking
registry and randomly assigned to early or delayed intervention. This 6-month intervention is multimodal, involving
patient prompts, clinician prompts, and outreach. At the time of the patient visit, eligible patients receive a low-
literacy patient education tool. At the same time, clinicians receive a prompt to remind them to order the test and,
when appropriate, a tool designed to simplify colorectal cancer screening decision-making. Patient outreach
consists of personalized letters, automated telephone reminders, assistance with scheduling, and linkage of
uninsured patients to the local National Breast and Cervical Cancer Early Detection program. Interventions are
repeated for patients who fail to respond to early interventions. We will compare rates of screening between
randomized groups, as well as planned secondary analyses of minority patients and uninsured patients. Data from
the pilot phase show that this multimodal intervention triples rates of cancer screening (adjusted odds ratio 3.63;
95% CI 2.35 - 5.61).
Discussion: This study protocol is designed to assess a multimodal approach to promotion of breast and
colorectal cancer screening among underserved patients. We hypothesize that a multimodal approach will
significantly improve cancer screening rates.
The trial was registered at Clinical Trials.gov NCT00818857
Background
Poor, underserved-minority, and uninsured patients have
lower rates of cancer screening than other Americans.
Lower rates of screening contribute to disparities in can-
cer mortality. For example, African Americans have
higher incidence of colorectal cancer (CRC), yet are
screened at lower rates. This represents an example of
the inverse care law (similar to the treatment-risk para-
dox [1]) whereby those with the greatest health care
need (in this case higher need for screening) are least
likely to receive care [2].
This unfortunate paradox in cancer screening likely
results from a combination of fewer resources available
to patients and fewer resources available to safety net
practices serving poor, minority and/or uninsured
patients. Underserved patients often face insurance [3,4]
and other financial barriers, [5] in addition to barriers
related to knowledge, [6,7] mistrust, [8] limited English
proficiency (LEP), [9] self efficacy, [10-12] and health
care literacy [13]. Underserved patients are more likely
to be cared for in under-resourced practices [14-16].
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ventions that improve cancer screening among under-
served patients. The first challenge is conceptual and
the second is methodological - sample selection bias.
The conceptual challenge results from the finding that
low-intensity cancer screening promotion interventions
may not necessarily help close gaps in cancer screening,
particularly if harder-to-reach groups respond at lower
rates to these interventions. For example, a single
reminder mailed out by health plans to patients who are
soon due for cancer screening yields higher screening
rates for patients with greater resources resulting in
increased screening disparities [17].
One way to address the unintended consequence of
increasing disparities is to invert the inverse care law
and allocate greater resources to patients who face
greater screening barriers. This approach has been suc-
cessfully used to eliminate community-wide disparities
in other preventive services, particularly immunizations
[18]. In this case, Szilagyi et al implemented reminders,
recall and outreach within safety net practices. They
compiled practice-based registries, among all eligible
patients (not a selected subsample) and implemented a
combination of in-reach (clinician prompts at the time
of patient visits) and outreach to patients past due using
increasingly intensive interventions (letter, phone calls
and even home visits) to families that failed to respond
to less intensive interventions. We derived principles
from their project and applied these principles to cancer
screening.
Principles for addressing disparities in cancer screening
We adapted the following four principles to promotion
of mammography and colorectal cancer screening:
1) Patients needing clinical services are identified using
data from primary care practices
Although this approach does not reach all persons, i.e.
those not registered at a primary care practice, it bet-
ter targets resources to unscreened persons than
broad-based community approaches. Also, most rando-
mized controlled trials formally enroll patients, leading
to sample selection bias because harder-to-reach
patients are more difficult to reach for enrollment.
Results from these trials - particularly those involving
outreach - may not readily apply to harder-to-reach
groups. By identifying patients from primary care prac-
tices and embedding the intervention in the care of
randomly selected patient care, we skirt this potential
bias.
2) Resources are focused on practices that care for large
numbers of underserved patients
Underserved patients often cluster within relatively few
practices; focusing on these practices directs resources
to where they are needed the most.
3) Personal physician recommendations are leveraged to
promote preventive services
Physicians almost universally endorse cancer screening
[19]. However, high rates of physician recommendations
for screening are not supported by either chart docu-
mentation [20] or patient report [21]. Clinicians’ appar-
ent failure to recommend cancer screening despite their
best intentions is likely attributable to competing
demands for their time and attention during busy offices
visits, [22,23] such as management of multiple acute
problems, chronic illnesses, psychosocial problems, com-
pletion of documentation, referrals, and phone calls.
Competing demands reduce rates of the delivery of pre-
ventive services, [24,25] including cancer screening [26].
Prompting clinicians may help, [27,28] but is only rele-
vant to patients who come in for care and clinicians
may inadvertently disregard prompts [29]. Patient
prompts combined with outreach to patients may com-
plement clinician prompts at point-of-care.
4) Outreach directs increasingly intensive interventions to
those who have failed to respond to earlier interventions
This focuses more intensive resources on those who are
harder-to-reach.
This project aims to address both conceptual and
sample selection limitations. It adopts a multimodal
approach to screening promotion and evaluates it
through a randomized controlled trial with minimal
selection bias in enrollment.
Methods/Design
Study design
We use a pragmatic, randomized controlled trial to eval-
uate this multimodal intervention with the patient as the
unit of randomization. This allows for direct comparison
of cancer screening rates (intervention vs. control
groups) among patients who at the outset are past due
for mammography or colorectal cancer screening. We
chose to randomize at the patient level rather than phy-
sician or physician group level because it is difficult to
ensure comparability when randomizing relatively small
numbers of physicians or physician groups. It should be
noted that patient-level randomization allows for physi-
cian learning effects, which bias results towards the null
so results from this trial may be conservative.
The study design is shown in Figure 1. Individual
patients are randomized and receive the 6 month inter-
vention. Twelve months following randomization the
delayed group also receives intervention. The primary
analysis will be based on comparison of screening rates
of patients in the early group who receive the interven-
tion with those in the delayed group who receive usual
care during the same time period. To account for lags
between referral and completion of screening, rates of
screening will be compared over 12 months.
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We recruited one large safety net practice in Rochester,
NY to participate in this trial. Given our aim of evaluat-
ing the impact of this multimodal intervention on dispa-
rities in cancer screening, we targeted a practice that
serve large numbers of low-income and minority
patients.
Participant consent, eligibility and randomization
The study was approved by the Institutional Review
Board of the University of Rochester. Participant
informed consent was waived by the Institutional
Review Board because the study poses no greater risk to
participants than that associated with routine care, parti-
cipants are free to ignore in-reach or outreach and may
request that they receive no further reminders at any
time.
Participant eligibility criteria for enrollment in the
study include: (1) being a registered patient at the prac-
tice (we used a single download from the health system
to create a practice registry); (2) having at least one visit
to the practice in the past two years (to ensure partici-
pants were actively receiving care at the practice); (3)
being ages 40-75 years for mammography screening,
and 50-75 years for CRC screening; (4) being past due
for annual mammography or CRC screening [(recom-
mended intervals are 10 years for those screened
through colonoscopy, 5 years for those screened with
sigmoidoscopy and/or barium enema, and annually for
those screened through fecal occult blood tests (FOBT)].
Women ages 50-75 could be enrolled based on either or
both mammography and CRC criteria. Patients at higher
risk for cancer due to prior cancer, premalignant condi-
tions, inadequately evaluated breast mass, or positive
FOBT were not randomized. Higher risk patients were
excluded from randomization due to ethical concerns;
clinicians were notified if chart review revealed they
were overdue for screening.
Potentially eligible participants were identified using
practice billing data based on age, sex and last visit to
Figure 1 Patient flow.
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presence and type of insurance, name of the primary
care physician, and contact information were imported
into a secure, customized patient tracking registry that
was created in Microsoft Access®. Last dates of screening
were determined through manual review of the electro-
nic medical record (EMR) by research assistants using
structured abstract formst od e t e r m i n ei f ,w h e na n d
how participants were last screened.
After a research assistant determined eligibility, the
off-site, statistician - blinded to all patient information
not needed for stratification - assigned patients to early
(intervention) or delayed (control) intervention using
computer-generated random numbers. Randomization
was stratified by screening type (mammography or
CRC) to ensure that comparable groups of patients are
randomized to each arm. Unique ID numbers were
assigned to patients that identify their intervention
group. The statistician maintained the key; all other
study personnel were blinded to the intervention group
assignment. The encoded sequences were affixed to the
Case Report File (CRF) as well as the patient chart.
Patients in both the intervention and control groups are
followed for one year.
Description of the intervention
The intervention, referred to as “Get Screened,” builds
on the finding that multimodal initiatives are more
powerful for promoting use of preventive services [30].
We use paper prompts that are delivered to the clinician
and patient immediately prior to the visit by office med-
ical assistants. No more than three prompts are deliv-
ered for the same patient. One research assistant uses
the EMR to indentify unscreened patients in the inter-
vention group who have impending visits in during the
week. She organizes patients by day of week into an
accordion folder and delivers this to each suite within
the large practice.
Clinician Prompt
We designed clinician-friendly, paper prompts that indi-
cate that the patient is past due for mammography and/
or CRC screening. We piloted the prompt sheet and
obtained feedback from clinicians in the practice. CRC
screening involves a number of different potential
screening modalities [31]. Based on our discussions with
community practices and local imaging centers, we have
found that FOBT and colonoscopy were primarily used;
flexible sigmoidoscopy, double contrast barium enema,
and virtual colonoscopy were seldom used to screen for
CRC locally. The back of each prompt sheet includes a
brief summary of the relative advantages and limitations
for each screening modality intended to facilitate clini-
cian-patient discussion. The outreach worker also
delivers fecal immunochemical testing kits to the prac-
tice and instructs medical assistants in how to counsel
patients in their use and how to complete the test requi-
sition. Fecal immunochemical tests and referral forms
for colonoscopy are made available at the time of the
patient visit.
Patient Prompts
We designed a simple patient prompt based on a low-
literacy tool used to prompt patients to request pneu-
mococcal vaccination [32]. We piloted the tool and
received suggestions from our community-advisory
board.
Patient Outreach
Outreach to unscreened patients consists of two persona-
lized letters and up to four automated telephone remin-
der (ATR) calls. The letter is signed by the patient’s
primary care clinician and indicates that the patient is
overdue for screening and why screening is important. It
includes relevant phone numbers including how unin-
sured patients can obtain free screening. The automated
telephone reminders are scripted, pre-recorded messages
that include the patient’s first name. The message identi-
fies the caller and the practice; it then informs the patient
s/he is past due and the phone number to call to sche-
dule a screening (mammography) or an appointment (to
discuss CRC). A completed call is defined as an answered
call (either in person or a machine).
The first letter is sent within the first week of enroll-
ment. This is followed by two completed ATRs at week
2 and 6 [33,34]. For patients who remain unscreened, a
second letter is mailed out at week 12 followed by a
third ATR at week 14. For patients past due for CRC
screening, the letter includes a testing kit for fecal
immunochemical testing for home use. A final ATR is
made at week 26.
Both the letters and ATRs provide the phone number
of the outreach worker if help is needed. Using a three
way call option, the outreach worker can link patients
with mammography schedulers or with the National
Breast and Cervical Cancer Early Detection Program
(NBCCEP), which provides free screening for the unin-
sured [35].
Creation of patient tracking registry
We were unable to identify a commercially available
tracking registry that met our study requirements.
Hence, we designed our own registry using Microsoft
Access®. The key functionalities of the registry include:
1) Electronic importation of data from billing data
(patient name, age, gender, race, ethnicity, insurance
type, primary care clinician, contact information,
date of last patient visit).
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restricted access to different fields based on unique
passwords. For example, the outreach worker only
has access to data for patients assigned to the inter-
vention. Similarly, research assistants are blinded to
group assignment and related data.
3) Tracking includes the date of all interventions
(prompts, letters and phone calls) and date and type
of cancer screening.
4) Report writing - ability to generate reports on
patients based on types and dates of interventions
received or other key fields.
5) Patient screening test results are used to update
the registry facilitating removal of screened patients
from further intervention.
Description of usual care
All patients randomized to the delayed intervention
receive “usual care” during the twelve months following
randomization. In this practice, the clinician (family
physician, nurse practitioner, or physician assistant) is
responsible for discussing cancer screening with the
patient and for initiating any referral or for handing out
FOBT cards. The EMR has a section called health main-
tenance profile that allows for input of the last screening
date to be entered and generation of alerts for future
screening. However, discussion with clinicians suggests
that this feature is not clinician-friendly and is seldom
used due to time constraints. Instead, each clinician has
h i s / h e ro w nm e t h o df o rt r a c k i n gc a n c e rs c r e e n i n g .I n
our pilot site, many clinicians reported not having orga-
nized systems for contacting patients overdue for
screening outside of scheduled visits.
Baseline and follow-up measures
Table 1 lists the baseline measures abstracted by a
research assistant who is blinded to group assignment.
The primary outcome measure is medical record docu-
mentation of completed mammography or any type of
CRC screening during the 12 months following rando-
mization. Covariates including age, gender, race, ethni-
city, insurance, number of visits in year prior to
randomization and comorbidity (based on the number
of problems listed on patient problem lists) will be used
to compare key characteristics of early and delayed
groups and test for interactions.
Role of the community health worker
The CHW functions as both an outreach worker and
practice facilitator. S/he uses the patient registry to
identify patients who are unscreened and implement
outreach either mailing out letters or responding to
phone calls to patients, and mailing out FOBT kits to
unscreened patients. S/he functions as a practice facilita-
tor by working with each practice to implement a tai-
lored system for reminders to patients and clinicians,
and also to facilitate referrals of patients who request
them for mammography or colonoscopy.
Preliminary data
In 2009, we piloted the intervention using the eligibility
criteria described above. In the mammography arm, 270
women met eligibility criteria for enrollment and 323
men and women met eligibility criteria for enrollment
in the CRC arm. The sample was middle aged (22% 40-
49 years, 48% 50-59 years, and 29% 60 years and older)
and 70% female. Distribution of race/ethnicity was 61%
White, 28% Black, 5% Hispanic, and 5% Asian. Health
insurance distribution was 42% private (including sup-
plemental private insurance for Medicare), 25% Medi-
caid, 23% Medicare only, and 9% uninsured.
For the pilot study (but not for the main study)
patients were assigned to early v. delayed intervention
based on their medical record number. The characteris-
tics of the two groups were similar. The pilot results are
Table 1 Baseline measures
Category Baseline Measure
Demographics Age (years), sex (male/female, race (White, African American/Black, Asian other), Hispanic ethnicity (yes/no), and insurance
(yes/no) and if yes
Insurance Any (Yes/No)
Type (Private, Medicare, Medicaid), HMO (Yes/No)
Visit Utilization Number of visits in year preceding randomization
Comorbidity Number of conditions listed on patient problem list
Cancer risk Breast cancer risk factors (prior breast cancer, BCRA, family history)
CRC risk factors (Prior polyp, inflammatory bowel disease, genetic condition)
Cancer screening
history
Date of last mammogram and results (Normal/Abnormal)
Date, type, and results (Normal/Abnormal) of CRC screening:
Colonoscopy
FOBT
Sigmoidoscopy
Double contrast barium enema
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due had very low rates of screening in the subsequent
12 months. Second, rates of screening were three times
higher in the intervention compared to the control
group. Because the patients were not randomized, but
inadvertently assigned based on medical record number,
we conducted a logistic regression model to predict
screening that controlled for participant characteristics.
These adjusted results from the pilot were similar to
our crude results from the pilot study (Odds Ratio 3.63;
95% CI 2.35- 5.61) for having any screening.
Sample Size determination
For the main study, based on the size of the recruited
practice and screening rates from the pilot study, we
estimate that 190 patients will be past due for mammo-
graphy and 239 will be past due for CRC screening.
Based on our pilot data, we anticipate rates of screening
of 18% and 10% respectively in the usual care (delayed
group). Based on our pilot data, we conservatively esti-
mate that this multimodal intervention will double
screening rates for both mammography and CRC
screening among those in the early intervention group.
Based on these assumptions, we will have a minimum of
80% power to detect a difference of 18% in the mammo-
graphy group and 13% in the colorectal screening group
using 95% confidence intervals.
Patient accrual and study flow
Patient flow for the main study is shown in figure 1. Of
the 525 women 40-75 years and men 50-75 years of age
that had a visit during the past two years, 148 had
undergone timely cancer screening. Of these and 10
were deemed higher risk and not eligible for randomiza-
tion. A total of 367 patients will be randomized to the
two groups.
Planned analytic approach
Intervention vs. control groups will be compared based
on intention-to-treat. That is, once randomized patients
will be included in the analysis regardless of whether
they leave the practice or not. We will use Generalized
Estimating Equation models to control for covariates
and clustering within practices. We also will assess
whether expected baseline differences in screening by
race, ethnicity and insurance are attenuated in the inter-
vention group. We will use a difference in difference
approach to assess whether the differences between
Whites and Blacks, Hispanics and non-Hispanics, and
insured and uninsured patients are significantly smaller
in the intervention (early) compared to usual care
(delayed group).
Discussion
“Get Screened” is a pragmatic, randomized controlled
trial of a multi-modal intervention designed to improve
mammography and CRC screening among unselected,
low-income patients. This intervention design builds
upon prior success in the field of immunization in
which multimodal, increasingly intensive interventions
improved immunizations across various patient charac-
teristics (e.g. race, ethnicity, and insurance) in safety net
practices and decreased disparities. Preliminary data
during the pilot study suggest that this multimodal
intervention could triple rates of screening in practices
with low baseline rates of screening. We hope to con-
firm these promising findings using a randomized, con-
trolled study design.
Other notable features of the project include patient-
level randomization, targeting of safety-net practices,
creation of a practice-based registry and a combination
of clinician and patient prompts at point-of-care com-
bined with increasingly intensive outreach to unscreened
patients.
Key challenges during early stages of implementation
have included limitations of the EMR, especially the lack
of an electronic alert system that clinicians actually use.
The finding that the EMR was poorly designed for
tracking preventive health services and providing remin-
ders, led to modification of our alert intervention plan.
It also presented an opportunity to populate this portion
of the EMR in order to promote future cancer screening
tracking within the practice. It is likely that many EMR
systems are similarly limited in the degree of practical
help they provide clinicians in improving rates of cancer
screening.
Another challenge involves developing an efficient sys-
tem for identifying patients who are screened during the
intervention period in order to focus resources on those
remaining unscreened. The complex range of CRC
screening choices was cited by participating clinicians as
a barrier to discussion of screening. This and other feed-
back from the practice was used during early pilot work
to modify and tailor the intervention. One modification
was the use of a simplified CRC point-of-care decision-
making tool that focused on the choice between colono-
scopy and FOBT testing. Findings from this study
should inform implementation of cancer screening
within safety net primary care practices.
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